{"paper_id":"10867704-fcf9-4d94-b8da-fa9e603f9ec7","body_text":"JOURNAL TOOLS |\n| Journal policies |\n| Publishing options |\n| eTOC |\n| To subscribe |\n| Submit an article |\n| Recommend to your librarian |\nARTICLE TOOLS |\n| Publication history |\n| Reprints |\n| Permissions |\n| Cite this article as |\n| Share |\nYOUR ACCOUNT\nYOUR ORDERS\nSHOPPING BASKET\nItems: 0\nTotal amount: € 0,00\nHOW TO ORDER\nYOUR SUBSCRIPTIONS\nYOUR ARTICLES\nYOUR EBOOKS\nCOUPON\nACCESSIBILITY\nLETTERS TO THE EDITOR Free access\nMinerva Medica 2025 April;116(2):168-9\nDOI: 10.23736/S0026-4806.25.09186-4\nCopyright © 2025 EDIZIONI MINERVA MEDICA\nlanguage: English\nThe treatment of adenomyosis-induced ovarian hyperstimulation syndrome with leuprolide\nCong YE 1, Bo ZHONG 1, Hui XU 2, Tong JIA 3, Hongling GUO 1 ✉\n1 Department of Gynecology, First People’s Hospital of Taicang City, Taicang, China; 2 Department of Ultrasound, First People’s Hospital of Taicang City, Taicang, China; 3 Department of Reproductive Health, Taicang Maternal and Child Health and Family Planning Service Center, Taicang, China","source_license":"CC0","license_restricted":false}